| NK Cells Study |
Characterization of innate Natural Killer Cells in Early HIV infection |
| Protocol O |
Human Explant Model to Study Immune Responses Associated with HIV-1 Infection |
| HIV Paed Drug Study |
A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to <18 years |
| WHO/STI |
Determining the Causes of Genital Discharge and Establishment of Sub-regional Reference Laboratory to support Gonococcal Antimicrobial Surveillance Programme in Africa |
| VZV Study |
An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya |
| Stem Cell study |
Establishment of assays for culture and manipulation of haematopoietic stem cells from cord blood and adipose cells- |
| Ebola 2 |
A Randomized, Observer-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo in Healthy Adults, Including |
| K001 |
Pre-screening of volunteers for potential participation in future clinical research (observational studies and clinical trials) at KAVI |
| L015 |
Characterization of population specific immune responses in support of HIV vaccine trials |
| IAVI LTFU |
Long Term Follow-up of study participants from IAVI sponsored clinical trials with HIV candidate vaccines |
